There is substantial evidence that the CXCR4/CXCL12 pathway also supports cancer development and survival by regulating angiogenesis and the trafficking of key immune cells in the tumor microenvironment (TME; ref. 5). The gene discussed is CXCR4; the disease is neoplasm.